Genetic targeting of proviral integration in stem cells

干细胞中原病毒整合的基因靶向

基本信息

批准号：
7625013
负责人：
Peter Kurre
金额：
$ 12.91万
依托单位：
OREGON HEALTH & SCIENCE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2005
资助国家：
美国
起止时间：
2005-07-04 至 2011-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7625013
关键词：
Advisory Committees Affect Area Awareness Biological Models Biology Biometry Cell Line Cells Classification DNA Engraftment Environment Event Exposure to Future Gene Expression Gene Transfer Genes Genetic Genetic Transcription Genomics Goals Gray unit of radiation dose Growth Factor Health Sciences Hematopoiesis Hematopoietic Hematopoietic stem cells Homing In Vitro Insertional Mutagenesis Lentivirus Vector Location Measures Mentors Mentorship Microarray Analysis Modeling Modification Moloney Leukemia Virus Mus Oregon Pattern Population Probability Property Reporting Research Personnel Research Proposals Risk Safety Shapes Site Stem cells Technology Testing Time Training Training Programs Transgenes Tumor Suppressor Genes Universities Work career cellular transduction cytokine gene replacement therapy gene therapy in vivo in vivo Model insight murine retroviral vector preference programs reconstitution response skills stem stem cell biology tool virology

项目摘要

DESCRIPTION (provided by applicant): The aim of this research proposal is to understand how transcriptional activity and its modification can be used to direct HIV-derived lentiviral vector integration in hematopoietic stem cells. Recent awareness of known lentiviral insertion site preferences for transcriptionally active genomic sites and reports of insertional mutagenesis after Moloney murine leukemia virus vector transduction of stem cells have highlighted the need to more fully investigate the biology of proviral integration. I herein propose to develop in vitro and in vivo model systems to explore strategies that should ultimately minimize insertion related risks of HIV-lentiviral gene replacement therapy. We hypothesize that systematic modifications in the transcriptional profile of hematopoietic target cells may serve to "attract" insertion events to specific genomic locations while minimizing mutagenic potential and transcriptional interference at others, such as oncogenes and tumor suppressor loci. Critically, the proposed in vivo studies will aim to reconcile the competing requirements for transcriptional profiling and efficient lentiviral gene transfer with the retention of stem cell properties, including target cell engraftment and long-term repopulation. These studies will provide mechanistic insight into how transcription, be it a surrogate, or a causally related event, affects proviral insertion, and will inform future studies for genomic targeting. The proposed mentored training program will help me acquire additional skills and gain understanding through the mentorship by Dr. David Kabat and Dr. Markus Grompe, and their scientific expertise in virology and stem cell biology, respectively. The proposal is further augmented by input and guidance from advisors/collaborators in the areas of hematopoiesis, DNA array technology, and biostatistics, as well as course work. A career advisory committee will help direct my progress to independence and career advancement. The comprehensive training environment at Oregon Health & Science University (OHSU) and the substantial institutional commitment to my career will allow me to accomplish the goals of this proposal.

描述（由申请人提供）：该研究建议的目的是了解转录活性及其修饰如何用于指导造血干细胞中的HIV衍生的慢病毒载体整合。最近对转录活性基因组部位的已知慢病毒插入部位偏好的认识，以及在莫洛尼鼠白血病病毒病毒载体转导干细胞后的插入诱变的报道，突显了需要更全面地研究病毒整合的生物学。我在这里建议开发体外和体内模型系统，以探索最终应最大程度地降低HIV静脉病毒基因替代疗法插入风险的策略。我们假设造血靶细胞的转录曲线中的系统修饰可能有助于将插入事件“吸引”到特定的基因组位置，同时最大程度地减少对他人的诱变潜力和转录干扰，例如肿瘤基因和肿瘤抑制基因座。至关重要的是，所提出的体内研究将旨在调和转录分析和有效的慢病毒基因转移的竞争要求，并保留干细胞特性，包括靶细胞植入和长期重生。这些研究将提供有关转录，无论是替代物或因果关系事件的方式，都会影响病毒插入，并将为未来的基因组靶向研究提供信息。拟议的指导培训计划将帮助我获得更多的技能，并通过David Kabat博士和Markus Grompe博士的指导以及他们在病毒学和干细胞生物学方面的科学专业知识。顾问/合作者在造血，DNA阵列技术和生物统计学以及课程工作。职业咨询委员会将有助于将我的进步转移到独立性和职业发展。俄勒冈州健康与科学大学（OHSU）的综合培训环境以及对我职业生涯的实质性制度承诺将使我能够实现这一建议的目标。